Clinical Trials Browser

Resectable Non-small Cell Lung Cancer × osimertinib × 1 year × Clear all

NCT07038460 2025-06-26

NEO-LISI

Phase 2 Not yet recruiting

Resectable Non-small Cell Lung Cancer